Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MOR:GR

76.099 EUR 0.300 0.39%

As of 11:35:19 ET on 01/30/2015.

Snapshot for MorphoSys AG (MOR)

Open: 76.500 Day's Range: 75.810 - 77.600 Volume: 126,343
Previous Close: 76.399 52wk Range: 53.700 - 90.000 1-Yr Rtn: +17.93%

Stock Chart for MOR

No chart data available.
  • MOR:GR 76.039
  • 1D
  • 1M
  • 1Y
76.399
Interactive MOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MOR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.2200
Est. EPS (EUR) (12/2014) -0.1660
Est. PEG Ratio -
Market Cap (M EUR) 2,013.34
Shares Outstanding (M) 26.46
30 Day Average Volume 152,572
Price/Book (mrq) 5.6753
Price/Sale (ttm) 31.7022
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MOR

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MOR

MorphoSys AG is a biotechnology company. The Company uses proprietary technology to develop human antibodies tailored to treat specific diseases. MorphoSys is developing medicines to treat cancer and inflammation.

Simon E MoroneyChairman-Mgmt Board/CEOJens HolsteinChief Financial Officer
Marlies SprollChief Scientific OfficerArndt SchotteliusChief Development Officer
More Company Profile & Key Executives for MOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil